IL-4R appears as a plausible candidate to attenuate metastatic tumor growth, especially since previous evidence demonstrated how antibody-mediated IL-4R neutralization lessened metastatic lung tumor burden and IL-4Rα loss reduced metastatic tumor growth [13]. Here, IL4R is linked to metastatic neoplasm.